Depo-Medrol Lidocaine 40 mg/mL, Injektionssuspension

7680385460151 CH-38546 Injektionssuspension
Depo-Medrol Lidocaine 40 mg/mL, Injektionssuspension
Depo-Medrol Lidocaine 40 mg/mL, Injektionssuspension
Depo-Medrol Lidocaine 40 mg/mL, Injektionssuspension
1 / 3
google

Article details

Package size
1 x 1 mL
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
01/08/2025
Summary of Product Characteristics
Français
01/08/2025
Summary of Product Characteristics
Italien
01/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
8.7 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
2.63 MG Substance HBESI

Reimbursement information

Public price
CHF 13.90
Specialties list
Yes
Generic
No
SL addition date: 15/03/1976

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
38546
Drug name
Depo-Medrol Lidocaine, Injektionssuspension
Galenic form
SUPA
ATC Code
H02BX01
Authorization status
Z
Dispensing category
B
First authorization
03/02/1975
Authorization expiration date
31/12/9999
IT Number
07.07.23
Domain
Human medicine
Field of application
Lokale Glukokortikoid-Therapie

Package details

Description (FR)
DEPO-MEDROL Lidocaïne 40 mg/ml flac 1 ml
Description (DE)
DEPO-MEDROL Lidocaine 40 mg/ml Durchstf 1 ml
Market launch
03/02/1975
Narcotic (BTM)
No

Other package sizes (2)

DEPO-MEDROL Lidocaïne 40 mg/ml 25 flac 1 ml
25 x 1 mL DUR
GTIN: 7680385460311
View
DEPO-MEDROL Lidocaïne 80 mg/2ml flac 2 ml
1 x 2 mL DUR
GTIN: 7680385460236
View